SCHEMBL7218008

SCHEMBL7218008

O=C(O)C1=Cc2cc(OCc3ccc(F)cc3)ccc2CCC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRB P28702 4/20 0.57
RXRA P19793 3/20 0.57
RXRG P48443 3/20 0.57
NPC1 O15118 3/20 0.57
RAB9A P51151 3/20 0.57
MAOB P27338 5/20 0.55
MAOA P21397 4/20 0.55
NR4A2 P43354 2/20 0.51
ALDH1A1 P00352 1/20 0.48
TP53 P04637 1/20 0.48
MAPT P10636 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
POLB P06746 1/20 0.48
GFER P55789 1/20 0.48
PAX8 Q06710 1/20 0.48
KLF5 Q13887 1/20 0.48
MRGPRX4 Q96LA9 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
HRH3 Q9Y5N1 3/20 0.47
HPD P32754 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7216359 0.90 NPC1 (0.56) RXRBRXRARXRGNPC1RAB9A
SCHEMBL7222242 0.89 MAOB (0.57) RXRBRXRARXRGNPC1RAB9A
SCHEMBL7222385 0.88 NPC1 (0.55) RXRBRXRARXRGNPC1RAB9A
SCHEMBL7222036 0.88 NPC1 (0.55) RXRBRXRARXRGNPC1RAB9A
SCHEMBL7222742 0.87 MAOB (0.52) RXRBRXRARXRGNPC1RAB9A
SCHEMBL7215895 0.85 MAOB (0.49) RXRBRXRARXRGNPC1RAB9A
SCHEMBL7216468 0.84 RXRB (0.47) RXRBRXRARXRGNPC1RAB9A
SCHEMBL7216413 0.84 NPC1 (0.46) RXRBRXRARXRGNPC1RAB9A
SCHEMBL7222844 0.79 MAPT (0.53) RXRBRXRARXRGNPC1RAB9A
SCHEMBL7218045 0.78 MAOB (0.55) RXRBRXRARXRGNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6627651-B1 Exhibiting preventive and therapeutic effects against HIV infectious diseases wherein R1 is an optionally substituted five- or six-membered ring group; X1 is a free valency or the like; W is a divalent group and inhibitors of HIV (human TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-09-30 US disclosed
EP-1182195-A1 CYCLIC COMPOUNDS AND USES THEREOF Takeda Chemical Industries, Ltd. (JP) 2002-02-27 EP disclosed